Anxiety, Depression & Mood Disorders

About This Condition

Anxiety disorders and depression are the two most prevalent mental health conditions in the United States, affecting over 40 million and 21 million Americans respectively. Both are heterogeneous in their biology: while the serotonin-deficit model has dominated psychiatry for decades, the evidence now clearly supports multiple overlapping pathophysiologies — HPA axis dysregulation (chronic cortisol elevation), neuroinflammation, mitochondrial dysfunction, gut-brain axis disruption (the "second brain"), thyroid dysfunction, nutritional deficiencies (B12, folate, vitamin D, zinc, magnesium, omega-3), hormonal imbalance, and trauma-driven limbic sensitization. Treating all of these with a single SSRI is, by definition, inadequate for many patients.

Our Approach

We co-manage mood disorders with psychiatry or psychology for patients who need that level of care, but we evaluate and treat the metabolic and physiologic underpinnings that are routinely ignored. Our mood-focused workup includes thyroid full panel, sex hormones, vitamin D, B12 with MMA, folate (RBC), iron studies, hsCRP, fasting glucose/insulin, and AM cortisol. We utilize MTHFR and relevant pharmacogenomic testing when indicated — impaired folate methylation is a clinically significant and treatable driver of treatment-resistant depression. Omega-3 supplementation is dosed to Omega-3 Index optimization, not generic "take fish oil." We assess and address sleep disorders, given the bidirectional relationship between sleep architecture and mood. DPC structure means we have the time to actually follow through on this multi-system approach visit by visit.